TY - JOUR
T1 - Interplay between whole-genome doubling and the accumulation of deleterious alterations in cancer evolution
AU - TRACERx Consortium
AU - López, Saioa
AU - Lim, Emilia L.
AU - Horswell, Stuart
AU - Haase, Kerstin
AU - Huebner, Ariana
AU - Dietzen, Michelle
AU - Mourikis, Thanos P.
AU - Watkins, Thomas B.K.
AU - Rowan, Andrew
AU - Dewhurst, Sally M.
AU - Birkbak, Nicolai J.
AU - Wilson, Gareth A.
AU - Van Loo, Peter
AU - Jamal-Hanjani, Mariam
AU - Swanton, Charles
AU - Jamal-Hanjani, Mariam
AU - Wilson, Gareth A.
AU - Wu, Yin
AU - Stone, Richard Kevin
AU - Greco, Maria
AU - Moore, David
AU - Davies, Helen
AU - Kerr, Keith
AU - Robinson, Andrew
AU - Summers, Yvonne
AU - Califano, Raffaele
AU - Taylor, Paul
AU - Shah, Rajesh
AU - Booton, Richard
AU - Evison, Matthew
AU - Crosbie, Phil
AU - Joseph, Leena
AU - Bishop, Paul
AU - Chaturvedi, Anshuman
AU - Blackhall, Fiona
AU - Rogan, Jane
AU - Smith, Elaine
AU - Baker, Katie
AU - Carter, Mathew
AU - Krebs, Matthew G.
AU - Lindsay, C. R.
AU - Dive, Caroline
AU - Rothwell, Dominic G.
AU - Chemi, Francesca
AU - Tugwood, Jonathan
AU - Lawrence, David
AU - Stephens, Robert C.M.
AU - Booth, Sarah
AU - Danson, Sarah
AU - Edwards, John
PY - 2020/3/5
Y1 - 2020/3/5
N2 - Whole-genome doubling (WGD) is a prevalent event in cancer, involving a doubling of the entire chromosome complement. However, despite its prevalence and prognostic relevance, the evolutionary selection pressures for WGD in cancer have not been investigated. Here, we combine evolutionary simulations with an analysis of cancer sequencing data to explore WGD during cancer evolution. Simulations suggest that WGD can be selected to mitigate the irreversible, ratchet-like, accumulation of deleterious somatic alterations, provided that they occur at a sufficiently high rate. Consistent with this, we observe an enrichment for WGD in tumor types with extensive loss of heterozygosity, including lung squamous cell carcinoma and triple-negative breast cancers, and we find evidence for negative selection against homozygous loss of essential genes before, but not after, WGD. Finally, we demonstrate that loss of heterozygosity and temporal dissection of mutations can be exploited to identify novel tumor suppressor genes and to obtain a deeper characterization of known cancer genes.
AB - Whole-genome doubling (WGD) is a prevalent event in cancer, involving a doubling of the entire chromosome complement. However, despite its prevalence and prognostic relevance, the evolutionary selection pressures for WGD in cancer have not been investigated. Here, we combine evolutionary simulations with an analysis of cancer sequencing data to explore WGD during cancer evolution. Simulations suggest that WGD can be selected to mitigate the irreversible, ratchet-like, accumulation of deleterious somatic alterations, provided that they occur at a sufficiently high rate. Consistent with this, we observe an enrichment for WGD in tumor types with extensive loss of heterozygosity, including lung squamous cell carcinoma and triple-negative breast cancers, and we find evidence for negative selection against homozygous loss of essential genes before, but not after, WGD. Finally, we demonstrate that loss of heterozygosity and temporal dissection of mutations can be exploited to identify novel tumor suppressor genes and to obtain a deeper characterization of known cancer genes.
UR - http://www.scopus.com/inward/record.url?scp=85081371537&partnerID=8YFLogxK
U2 - 10.1038/s41588-020-0584-7
DO - 10.1038/s41588-020-0584-7
M3 - Article
C2 - 32139907
AN - SCOPUS:85081371537
SN - 1061-4036
VL - 52
SP - 283
EP - 293
JO - Nature Genetics
JF - Nature Genetics
IS - 3
ER -